Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Gannex Pharma presents new FXR agonists

May 9, 2022

Merck & Co. presents DGAT-2 inhibitors

April 29, 2022

Shenzhen Salubris Pharmaceuticals presents GLP-1 receptor agonists

April 26, 2022

Chinese investigators patent new THR-beta agonists

April 25, 2022

Ono establishes collaborations to discover small molecules targeting GPCRs in metabolic disease

April 20, 2022

Microbe-sensing mechanism via neuronal Nod2 regulates appetite and metabolism

April 19, 2022

Artelo reports new preclinical data for GPCR agonist ART-27.13 for cancer-induced cachexia

April 14, 2022

FGFR2-selective inhibitor CGT-0292 shows promise for treating hyperphosphatemia

April 13, 2022

UCL Business synthesizes new TTR stabilizers

April 11, 2022

Cadila Healthcare discloses new ACP1 inhibitors

April 8, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...